US 12,410,192 B2
Compound for inhibiting and inducing degradation of EGFR kinase
Yanping Zhao, Beijing (CN); Hongjun Wang, Beijing (CN); Yeming Wang, Beijing (CN); Yuanyuan Jiang, Beijing (CN); Futian Fan, Beijing (CN); Huining Liang, Beijing (CN); Xiaoqian Wang, Beijing (CN); Yong Xie, Beijing (CN); Yanhao Zhang, Beijing (CN); and Xuelian Liu, Beijing (CN)
Assigned to BEIJING TIDE PHARMACEUTICAL CO., LTD., Beijing (CN)
Appl. No. 17/785,608
Filed by BEIJING TIDE PHARMACEUTICAL CO., LTD., Beijing (CN)
PCT Filed Dec. 16, 2020, PCT No. PCT/CN2020/136773
§ 371(c)(1), (2) Date Jun. 15, 2022,
PCT Pub. No. WO2021/121261, PCT Pub. Date Jun. 24, 2021.
Claims priority of application No. 201911291237.9 (CN), filed on Dec. 16, 2019.
Prior Publication US 2023/0159559 A1, May 25, 2023
Int. Cl. C07D 498/22 (2006.01); A61P 35/00 (2006.01)
CPC C07D 498/22 (2013.01) [A61P 35/00 (2018.01)] 20 Claims
 
1. A compound of general formula (I), or a pharmaceutically acceptable salt, enantiomer, diastereomer, racemate, solvate, hydrate, polymorph, prodrug, or isotopic variant thereof, or a mixture thereof:

OG Complex Work Unit Chemistry
wherein
custom character represents single bond or double bond;
----- represents that the point of attachment to the rest of the molecule can be located at an available point of a ring;
Z1 is O, S, N or C atom, which is optionally substituted with one or two RZ1;
Z2 is O, S, N or C atom, which is optionally substituted with one or two RZ2;
Z3 is O, S, N or C atom, which is optionally substituted with one or two RZ3; with the proviso that when custom character represents double bond, Z2 is N or C atom, and Z3 is N or C atom;
Z4 is N or CRZ4;
Z5 is N or CRZ5;
Ra, Rb and Rc are independently H, halogen, C1-6 alkyl or C1-6 haloalkyl;
RN1 is H, C1-6 alkyl or C1-6 haloalkyl;
RZ1 is absent, H, CN, halogen, C1-6 alkyl, or C1-6 haloalkyl; or two RZ1 are taken together with Z1 to form C═O;
RZ2 is absent, H, CN, halogen, C1-6 alkyl, or C1-6 haloalkyl;
RZ3 is absent, H, CN, halogen, C1-6 alkyl, or C1-6 haloalkyl; or two RZ3 are taken together with Z3 to form C═O;
RZ4 is H, CN, halogen, C1-6 alkyl, or C1-6 haloalkyl;
RZ5 is H, CN, halogen, C1-6 alkyl, or C1-6 haloalkyl;
L1 is selected from bond, —O—, —S(O)p—, —NR#—, —CR#R#′— or —CaR#R#′—CbR#R#′—;
L2 is selected from bond, —O—, —S(O)p—, —NR#—, —CR#R190 ′— or —CaR#R#′—CbR#R#′—;
wherein any one of CaR#R#′ or CbR#R#′ can be replaced by O, S(O)p or NR#, and when any one of CaR#R#′ or CbR#R#′ is replaced by O, S or NR#, the other of CaR#R#′ or CbR#R#′ can further be replaced by S(O)q;

OG Complex Work Unit Chemistry
E is independently selected from: —CcR#R#′—CdR#R#′—CcR#R#′ or
wherein any one of CcR#R#′, CdR#R#′ or CeR#R#′, or both of CcR#R#′ and CeR#R#′ can be replaced by O, S(O)p or NR#, and when any one of CcR#R#′, CdR#R#′ or CeR#R# is replaced by O, S or NR#, the other one or two of CcR#R#′, CdR#R#′ or CeR#R#′ adjacent to it can further be replaced by S(O)q;
H4 and H5 are N or C atom;
p is 0, 1 or 2;
q is 1 or 2;
R# is H, halogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl or C2-6 alkynyl;
R#′ is H, halogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl or C2-6 alkynyl;
or, R# and R# on adjacent atoms can be taken together to form bond, and R#′ and R#′ on adjacent atoms can be taken together to form bond;
or, R# and R#′ on the same or different atoms can be taken together to form —O;
m is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10;
X1 is C or N atom;
X2 is C or N atom;
X3 is C or N atom;
X4 is O, S, C or N atom, which is optionally substituted with one or two R2;
X5 is O, S, C or N atom;
X6 is C or N atom;
X7 is O, S, C or N atom;
R1 is H, CN, halogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl or C2-6 alkynyl;
R2 is H, CN, halogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl or C2-6 alkynyl;
RN2 is H, C1-6 alkyl or C1-6 haloalkyl;
the definition of L1′ is the same as that of L1;
the definition of L2′ is the same as that of L2;
the definition of E′ is the same as that of E;
the definition of m′ is the same as that of m;
Rs1 is selected from H, CN, halogen, C1-6 alkyl or C1-6 haloalkyl;
Rs2 is selected from H, CN, halogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl or C2-6 alkynyl;
Rs3 is selected from H, CN, halogen, C1-6 alkyl or C1-6 haloalkyl;
Rs4 is selected from H, CN, halogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl or C2-6 alkynyl;
s1 is 0, 1, 2 or 3;
s2 is 0, 1, 2 or 3;
s3 is 0, 1 or 2;
s4 is 0, 1, 2, 3, 4 or 5.